학술논문
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
Document Type
Article
Author
Gainor, Justin F ; Curigliano, Giuseppe; Kim, Dong-Wan; Lee, Dae Ho; Besse, Benjamin; Baik, Christina S; Doebele, Robert C; Cassier, Philippe A; Lopes, Gilberto; Tan, Daniel S W; Garralda, Elena; Paz-Ares, Luis G; Cho, Byoung Chul; Gadgeel, Shirish M; Thomas, Michael; Liu, Stephen V; Taylor, Matthew H; Mansfield, Aaron S; Zhu, Viola W; Clifford, Corinne; Zhang, Hui; Palmer, Michael; Green, Jennifer; Turner, Christopher D; Subbiah, Vivek
Source
In The Lancet Oncology July 2021 22(7):959-969
Subject
Language
ISSN
1470-2045